HealthCor Management as of June 30, 2022
Portfolio Holdings for HealthCor Management
HealthCor Management holds 56 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Boston Scientific Corporation Call Option (BSX) | 8.6 | $86M | 2.3M | 37.27 | |
| Biogen Idec (BIIB) | 8.5 | $84M | 414k | 203.94 | |
| Horizon Therapeutics Pub L SHS | 7.2 | $72M | 904k | 79.76 | |
| BioMarin Pharmaceutical (BMRN) | 6.2 | $61M | 741k | 82.87 | |
| Centene Corporation (CNC) | 4.6 | $46M | 541k | 84.61 | |
| UnitedHealth (UNH) | 3.5 | $35M | 68k | 513.63 | |
| Natera (NTRA) | 3.2 | $32M | 898k | 35.44 | |
| Bristol Myers Squibb (BMY) | 3.2 | $32M | 412k | 77.00 | |
| Livanova SHS (LIVN) | 3.1 | $30M | 487k | 62.47 | |
| Chemocentryx Call Option | 3.0 | $30M | 1.2M | 24.78 | |
| Hologic (HOLX) | 2.8 | $28M | 402k | 69.30 | |
| Tenet Healthcare Corp Com New (THC) | 2.7 | $27M | 519k | 52.56 | |
| Anthem (ELV) | 2.6 | $26M | 54k | 482.57 | |
| Cigna Corp (CI) | 2.6 | $25M | 97k | 263.52 | |
| Danaher Corporation (DHR) | 2.5 | $25M | 97k | 253.52 | |
| Eli Lilly & Co. (LLY) | 2.3 | $23M | 71k | 324.22 | |
| AmerisourceBergen (COR) | 2.2 | $22M | 157k | 141.48 | |
| Humana (HUM) | 2.2 | $22M | 47k | 468.06 | |
| Abbott Laboratories (ABT) | 2.2 | $22M | 199k | 108.65 | |
| Revance Therapeutics | 2.0 | $20M | 1.4M | 13.82 | |
| Henry Schein (HSIC) | 1.9 | $19M | 249k | 76.74 | |
| Cytokinetics Com New (CYTK) | 1.9 | $19M | 486k | 39.29 | |
| Seagen | 1.8 | $18M | 103k | 176.94 | |
| Incyte Corporation (INCY) | 1.8 | $18M | 234k | 75.97 | |
| Syndax Pharmaceuticals (SNDX) | 1.8 | $18M | 923k | 19.24 | |
| Agilent Technologies Inc C ommon (A) | 1.7 | $16M | 138k | 118.77 | |
| Intuitive Surgical Com New (ISRG) | 1.5 | $15M | 73k | 200.70 | |
| Becton, Dickinson and (BDX) | 1.4 | $14M | 56k | 246.53 | |
| Universal Hlth Svcs CL B (UHS) | 1.4 | $14M | 134k | 100.71 | |
| McKesson Corporation (MCK) | 1.1 | $11M | 35k | 326.20 | |
| Kezar Life Sciences | 1.0 | $10M | 1.2M | 8.27 | |
| Cooper Cos Com New | 1.0 | $9.6M | 31k | 313.13 | |
| Zimmer Holdings (ZBH) | 0.8 | $7.6M | 72k | 105.05 | |
| Ishares Tr Ishares Biotech (IBB) | 0.6 | $6.3M | 54k | 117.63 | |
| Hyperfine Com Cl A (HYPR) | 0.6 | $6.1M | 2.7M | 2.23 | |
| Dex (DXCM) | 0.6 | $5.6M | 75k | 74.53 | |
| Affimed Therapeutics B V | 0.5 | $4.8M | 1.7M | 2.77 | |
| Select Sector Spdr Tr Sbi Healthcare (XLV) | 0.4 | $4.4M | 35k | 128.23 | |
| Rapt Therapeutics | 0.4 | $4.0M | 217k | 18.25 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.4 | $3.8M | 500k | 7.52 | |
| Quanterix Ord (QTRX) | 0.3 | $3.3M | 202k | 16.19 | |
| Galapagos Nv Spon Adr (GLPG) | 0.3 | $3.1M | 55k | 55.81 | |
| Merus N V (MRUS) | 0.3 | $2.7M | 119k | 22.64 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $2.5M | 240k | 10.58 | |
| Align Technology Call Option (ALGN) | 0.2 | $2.4M | 10k | 236.70 | |
| ImmunoGen | 0.2 | $2.3M | 500k | 4.50 | |
| Insulet Corporation (PODD) | 0.2 | $1.6M | 7.2k | 217.90 | |
| Geron Corporation (GERN) | 0.2 | $1.6M | 1.0M | 1.55 | |
| Intra Cellular Therapies (ITCI) | 0.2 | $1.5M | 27k | 57.07 | |
| Leap Therapeutics | 0.1 | $1.2M | 1.1M | 1.15 | |
| Ikena Oncology (IKNA) | 0.1 | $975k | 220k | 4.43 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $81k | 100k | 0.81 | |
| Longview Acquisition Corp Ii *w Exp 99/99/999 | 0.0 | $56k | 427k | 0.13 | |
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $15k | 83k | 0.18 | |
| Orion Acquisition Corp *w Exp 02/19/202 | 0.0 | $12k | 137k | 0.09 | |
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $2.0k | 78k | 0.03 |
